Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-10-024764
Filing Date
2010-03-15
Accepted
2010-03-15 17:08:59
Documents
7
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K c97731e10vk.htm 10-K 1214367
2 EXHIBIT 23.1 c97731exv23w1.htm EX-23.1 1938
3 EXHIBIT 31.1 c97731exv31w1.htm EX-31.1 8463
4 EXHIBIT 31.2 c97731exv31w2.htm EX-31.2 8775
5 EXHIBIT 32.1 c97731exv32w1.htm EX-32.1 3407
6 EXHIBIT 32.2 c97731exv32w2.htm EX-32.2 3447
7 GRAPHIC c97731c9773101.gif GRAPHIC 16822
  Complete submission text file 0000950123-10-024764.txt   1265111
Mailing Address 4520 EAST-WEST HIGHWAY, SUITE 300 BETHESDA MD 20814
Business Address 4520 EAST-WEST HIGHWAY, SUITE 300 BETHESDA MD 20814 3019613400
Sucampo Pharmaceuticals, Inc. (Filer) CIK: 0001365216 (see all company filings)

EIN.: 133929237 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33609 | Film No.: 10682436
SIC: 2834 Pharmaceutical Preparations